ANP Technologies, Inc. currently offers two types of COVID-19 test.

These rapid, portable test kits provide accurate, reliable results in

15 minutes.

LEARN MORE

NIDS® COVID-19 Rapid Tests

News and Press Releases

1/2

Our Technologies

Defense

Our NIDS® rapid and handheld assays are widely used by the U.S. military and first responders to detect biological and chemical agent threats.

Defense Products

Therapeutics

Using its library of patented polymers, ANP has successfully nanoencapsulated both small and large molecule drugs to improve pharmacokinetics, reduce toxicity, and enhance therapeutic efficacy, & stability. ANP has multiple drugs at the IND stage or beyond!

ANP Pipeline

Immunogenicity

ANP has the best immunogenicity testing products on the market including the renowned ANPEG-1 IgM antibody, comprehensive PEG ELISA Kits, and customizable kits for any application.

Immunogenicity Products

Life Science

We offer a premier portfolio of life science products including ANPEG Antibody, Streptavidin & Neutravidin ELISA Plates, Protein Labeling & Extraction Kits, Reagents, & more.

Life Science Products

Defense/Biological Warfare Customer Feedback

First-rate Support for Correcting Operational Errors

“ANP’s on-site technical support team is awesome! We ran into some testing problems with the NIDS® multiplexed hand held assays and reader during initial testing. Upon our request, ANP immediately sent their tech support team to our test site and helped us to quickly identify the problem which was caused by insufficient sample volume. After that, there have been no problems what’s so ever. Thank you ANP! We truly appreciate your technical expertise and professionalism!”

ANP Technologies, in Partnership with Fulgent Pharma, Teams with Moffitt Cancer Center to Develop a New Class of Leukemia Therapies

ANP Technologies, in Partnership with Fulgent Pharma, Teams with Moffitt Cancer Center to Develop a New Class of Leukemia Therapies

ANP Technologies Achieves ISO 9001:2008 Certification for Quality Management

The U.S. Food and Drug Administration (FDA) has granted approval for ANP Technologies, Inc. and its partner to begin Phase I clinical trials with its first drug – nanoencapsulated paclitaxel.

ANP Technologies®, Inc.

A Leader in Biodefense and Nanotherapeutics

ANP Technologies, Inc. currently offers two types of COVID-19 test.

These rapid, portable test kits provide accurate, reliable results in

15 minutes.

NIDS® COVID-19 Rapid Tests

News and Press Releases

Business Wire

Bloomberg

Our Technologies

Defense

Therapeutics

Immunogenicity

Life Science

Defense/Biological Warfare Customer Feedback

First-rate Support for Correcting Operational Errors

WHO WE SERVE

Pharmaceutical Industry

Drug Developers

Defense & First Responders

Contract Research Organizations

Academic Institutions

Government